Also known as آسٹیوپوروسس مینجمنٹ
General Physician
M.B.B.S., M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Gastroenterologist
MBBS, FCPS, MD(USA)
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine) Gold Medalist, MRCGP int
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine) Gold Medalist, MRCGP int
General Physician
M.B.B.S , M.C.P.S (Family Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures